Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system
Bryant, Alex K, Lewy, Jacqueline R, Bressler, R Daniel, Chopra, Zoey, Gyori, Derek J, Bazzell, Brian G, Moeller, Julie A, Jacobson, Sofia I, Fendrick, A Mark, Kerr, Eve A, Ramnath, Nithya, Green, Michael D, Hofer, Timothy P, Vaishnav, Parth, Strohbehn, Garth W
Published in The lancet oncology (01.06.2024)
Published in The lancet oncology (01.06.2024)
Get full text
Journal Article